FundedIQ
Biotechnology

Oncoinvent: Funding, Investors & Team (Sep 2026)

Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns.

www.oncoinvent.com LinkedIn Oslo, Norway 11-50 employees
Biotechnology Chemical Life Science
Total raised
$11.7M
Rounds
1
Latest
Undisclosed round
Dec 2024

Oncoinvent has raised $11.7M across 1 funding round on record, the most recent an undisclosed round of $11.7M announced in Dec 2024.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Oncoinvent Company Profile and Key Stats

Total funding raised
$11.7M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$11.7M in Dec 2024
Employees
11-50
reported band
Headquarters
Oslo, Norway

Latest funding round on record: Dec 2024.

Oncoinvent Funding Rounds

Date
Round
Amount
Undisclosed round
$11.7M

Oncoinvent Founders and Leadership Team

Name
Role
Contact
Oystein Soug
Founder
Locked

Contact details for the Oncoinvent team: 1 of 1 has an email address on file.

Start 14-day free trial →

Oncoinvent Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
232
$8.7M

Oncoinvent's latest round of $11.7M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Oncoinvent in Biotechnology and Oslo

Companies Similar to Oncoinvent

Zelluna Immunotherapy AS is a privately owned Norwegian biopharmaceutical company founded in 2016 focused on…

Undisclosed round $1.6M

Hofseth BioCare's key goal is to offer high benefit added biomarine elements for human applications. Through…

Undisclosed round $14.6M

Circio Holding ASA is a company in the clinical stage that is developing immune activators for challenging…

Undisclosed round $31.5M

IDEX, a biometrics software and fingerprint authentication company based in Oslo, Norway, was established in…

Undisclosed round $8.6M

Arctic Bioscience is a biotechnology research company that develops products, solutions, and technologies…

Undisclosed round $1.5M

Lytix Biopharma AS is a privately-owned pharmaceutical company focussed on anti-microbials and cancer…

Undisclosed round $1.7M

Actithera is a company specializing in developing radioligand therapies through the application of medicinal…

Series A $75.5M

NoMy is a company focused on creating sustainable and scalable solutions for alternative proteins by…

Seed $1.4M

Biosergen AS develops variants of nystatin with improved properties. Its pipeline products include S44HP, an…

Undisclosed round $4.1M

NEXT offers secure and user-friendly fingerprint sensor technology for verification purposes in various…

Undisclosed round $3.7M

We are a speciality pharmaceutical business committed to the creation and marketing of goods for people who…

Undisclosed round $55.0M

Calluna has developed a robust pipeline of selective antibodies, targeting immunological diseases. These…

Series A $81.7M

Oncoinvent Funding FAQs

What does Oncoinvent do?

Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns.

How much funding has Oncoinvent raised?

Oncoinvent has raised $11.7M across 1 round on record. The most recent is an undisclosed round of $11.7M announced in Dec 2024.

When did Oncoinvent last raise funding?

Oncoinvent's most recent funding round on record is an undisclosed round of $11.7M, announced in Dec 2024.

Who founded Oncoinvent?

FundedIQ lists Oystein Soug (Founder) at Oncoinvent.

Where is Oncoinvent headquartered?

Oncoinvent is based in Oslo, Norway.

How many employees does Oncoinvent have?

Oncoinvent is in the 11-50 employee band.

How does Oncoinvent's funding compare to other Biotechnology startups?

Oncoinvent's latest round of $11.7M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Oncoinvent Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Oncoinvent is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.